November 2019

Pattern of hospital visits offers clue to spotting people at risk of myeloma

Glasgow, UK: A condition that can progress to myeloma could be identified in patients by their unusually frequent hospital visits, according to research presented at the 2019 NCRI Cancer Conference. The study found that people with a pre-cancerous blood condition called monoclonal gammopathy of undetermined significance (MGUS) made around twice as many visits to hospital […]

Researchers identify certain gut bacteria that may be involved in causing bowel cancer

Glasgow, UK: People who have a certain type of bacteria in their guts may be at greater risk of developing bowel cancer. In the first study to use a technique called Mendelian randomisation to investigate the causal role played by bacteria in the development of bowel cancer, Dr Kaitlin Wade, from the University of Bristol […]

Simple blood test for early detection of breast cancer

Glasgow, UK: Breast cancer could be detected up to five years before there are any clinical signs of it, using a blood test that identifies the body’s immune response to substances produced by tumour cells, according to new research presented at the 2019 NCRI Cancer Conference. Cancer cells produce proteins called antigens that trigger the […]

High levels of two hormones in the blood raise prostate cancer risk

Glasgow, UK: Men with higher levels of ‘free’ testosterone and a growth hormone in their blood are more likely to be diagnosed with prostate cancer, according to research presented at the 2019 NCRI Cancer Conference. Other factors such as older age, ethnicity and a family history of the disease are already known to increase a […]

Deaths from liver cancer have tripled in past 20 years in England

Glasgow, UK: More people are being diagnosed with and dying from liver cancer in England than ever before, according to new research presented at the 2019 NCRI Cancer Conference. In 20 years, from 1997 to 2016, incidence and deaths from the most common form of the disease, hepatocellular carcinoma (HCC), have tripled and it is […]